SCHEMBL19153229

SCHEMBL19153229

Cc1n[nH]c2c1CC[S+]([O-])C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19153766 0.77 PDPK1 (0.30) —
SCHEMBL12361762 0.67 HCAR2 (0.48) —
SCHEMBL12094375 0.67 — —
SCHEMBL20674140 0.66 TSHR (0.50) —
SCHEMBL19153868 0.63 — —
SCHEMBL19153783 0.63 HAVCR2 (0.33) —
SCHEMBL16124086 0.63 HTR7 (0.41) —
SCHEMBL17232727 0.60 CYP2C19 (0.55) —
SCHEMBL22212073 0.59 HCAR2 (0.32) —
SCHEMBL19154101 0.59 HAVCR2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170202970-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. 2017-07-20 — — US disclosed
Send feedback